Catalyst Wire Dossier Catalyst Wire Dossier

Omega-3 fatty acid-based anti-cancer therapy

· National Cancer Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Omega-3 fatty acid-based anti-cancer therapy, covering 2024-09-04 to 2024-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body [Phase 1, Phase 2]

See pricing